Back to calendar
NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NAMS reports earnings on Wednesday, August 12, 2026
earnings report
August 12, 2026 · Before Market Open
Est. EPS: $-0.50
Actual EPS: $-0.52
EPS surprise: -7.90%
Company overview
Market Cap$3.3B
PriceUSD 27.83
EPS (TTM)-2.18
52-week high42.20
52-week low23.05
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees100